Kolmar Korea Co., Ltd.

KOSE:A161890 Stock Report

Market Cap: ₩1.3t

Kolmar Korea Valuation

Is A161890 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A161890 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A161890 (₩54400) is trading below our estimate of fair value (₩135923.39)

Significantly Below Fair Value: A161890 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A161890?

Key metric: As A161890 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A161890. This is calculated by dividing A161890's market cap by their current earnings.
What is A161890's PE Ratio?
PE Ratio132.9x
Earnings₩9.66b
Market Cap₩1.28t

Price to Earnings Ratio vs Peers

How does A161890's PE Ratio compare to its peers?

The above table shows the PE ratio for A161890 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.9x
A192820 Cosmax
19.2x27.1%₩1.5t
14xn/a₩1.0t
22.2x27.6%₩2.0t
A241710 Cosmecca Korea
16.3x22.4%₩563.9b
A161890 Kolmar Korea
132.9x61.5%₩1.3t

Price-To-Earnings vs Peers: A161890 is expensive based on its Price-To-Earnings Ratio (132.9x) compared to the peer average (17.9x).


Price to Earnings Ratio vs Industry

How does A161890's PE Ratio compare vs other companies in the KR Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A900120 CXI Healthcare Technology Group
0.8xn/aUS$15.93m
No more companies available in this PE range
A161890 132.9xIndustry Avg. 16.0xNo. of Companies6PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A161890 is expensive based on its Price-To-Earnings Ratio (132.9x) compared to the KR Personal Products industry average (16x).


Price to Earnings Ratio vs Fair Ratio

What is A161890's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A161890 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio132.9x
Fair PE Ratio37.2x

Price-To-Earnings vs Fair Ratio: A161890 is expensive based on its Price-To-Earnings Ratio (132.9x) compared to the estimated Fair Price-To-Earnings Ratio (37.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A161890 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩54,400.00
₩87,550.00
+60.9%
10.3%₩110,000.00₩75,000.00n/a20
Nov ’25₩67,800.00
₩88,444.44
+30.4%
9.1%₩107,000.00₩75,000.00n/a18
Oct ’25₩74,400.00
₩85,117.65
+14.4%
12.7%₩107,000.00₩58,000.00n/a17
Sep ’25₩65,100.00
₩81,937.50
+25.9%
10.8%₩96,000.00₩58,000.00n/a16
Aug ’25₩66,100.00
₩74,562.50
+12.8%
10.2%₩89,000.00₩58,000.00n/a16
Jul ’25₩67,000.00
₩73,437.50
+9.6%
10.6%₩89,000.00₩58,000.00n/a16
Jun ’25₩64,300.00
₩69,125.00
+7.5%
9.0%₩77,000.00₩58,000.00n/a16
May ’25₩50,200.00
₩68,062.50
+35.6%
10.7%₩77,000.00₩56,000.00n/a16
Apr ’25₩51,500.00
₩68,875.00
+33.7%
10.3%₩77,000.00₩56,000.00n/a16
Mar ’25₩47,450.00
₩69,250.00
+45.9%
10.2%₩77,000.00₩56,000.00n/a16
Feb ’25₩49,150.00
₩69,000.00
+40.4%
10.4%₩77,000.00₩57,000.00n/a16
Jan ’25₩53,600.00
₩68,466.67
+27.7%
10.5%₩77,000.00₩57,000.00n/a15
Dec ’24₩47,350.00
₩68,500.00
+44.7%
10.9%₩77,000.00₩57,000.00n/a14
Nov ’24₩54,500.00
₩70,461.54
+29.3%
10.8%₩77,000.00₩52,000.00₩67,800.0013
Oct ’24₩51,100.00
₩69,727.27
+36.5%
12.3%₩77,000.00₩52,000.00₩74,400.0011
Sep ’24₩53,600.00
₩69,727.27
+30.1%
12.3%₩77,000.00₩52,000.00₩65,100.0011
Aug ’24₩48,850.00
₩56,818.18
+16.3%
6.5%₩64,000.00₩52,000.00₩66,100.0011
Jul ’24₩44,000.00
₩50,666.67
+15.2%
8.3%₩57,000.00₩41,000.00₩67,000.0012
Jun ’24₩38,350.00
₩50,416.67
+31.5%
8.0%₩57,000.00₩41,000.00₩64,300.0012
May ’24₩40,450.00
₩51,600.00
+27.6%
8.8%₩57,000.00₩41,000.00₩50,200.0010
Apr ’24₩41,900.00
₩51,666.67
+23.3%
9.5%₩58,000.00₩41,000.00₩51,500.009
Mar ’24₩40,700.00
₩52,600.00
+29.2%
10.4%₩59,000.00₩41,000.00₩47,450.0010
Feb ’24₩43,650.00
₩51,454.55
+17.9%
11.8%₩59,000.00₩40,000.00₩49,150.0011
Jan ’24₩42,600.00
₩50,090.91
+17.6%
15.0%₩59,000.00₩37,000.00₩53,600.0011
Dec ’23₩39,900.00
₩51,500.00
+29.1%
14.9%₩60,000.00₩37,000.00₩47,350.0012
Nov ’23₩34,800.00
₩53,272.73
+53.1%
17.8%₩67,000.00₩32,000.00₩54,500.0011

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies